GlassScriptPhysician profile
Alexis Harrison
NPI 1861646382
$1,195.60
in general payments reported to CMS, 2019-2025
17 companies · $14.67 in 2025
The $14.67 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $422 · 2020: $212 · 2021: $57.63 · 2022: $226 · 2023: $264 · 2025: $14.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $278.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $274.61 | 2022-2023 | Ffrct |
| Actelion Pharmaceuticals US, INC. | $193.97 | 2019-2023 | Uptravi, Opsumit |
| Biotronik INC. | $172.18 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $126.24 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $87.75 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.27 | 2019-2020 | |
| Amgen INC. | $47.76 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $44.05 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.10 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $33.80 | 2019 | |
| Amarin Pharma, INC. | $19.44 | 2020 | |
| Novartis Pharmaceuticals Corporation | $15.99 | 2019 | |
| Boston Scientific Corporation | $15.22 | 2023 | Watchman Flx |
| Mallinckrodt Hospital Products INC. | $14.85 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.67 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $14.25 | 2019 | |
| Mylan Specialty L.P. | $13.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexis Harrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.